摘要
目的:分析硝苯地平临床常用剂型治疗高血压的临床效果和经济效益。方法:将我院收治的120例高血压患者分为A组(硝苯地平控释片)、B组(缓释片)和C组(普通片)各40例。结果:三组治疗效果无显著差异(P>0.05),A组不良反应低于B组和C组,治疗成本高于B组和C组。结论:硝苯地平缓释片治疗成本不低,但服用简单,不良反应少,是适合治疗高血压的理想剂型。
Objective To analyze the clinical effect and economic returns of clinical common different dosage forms of Nifedipine for the treatment of hypertension. Methods 120 patients with hypertension were treated in our hospital, and all patients were randomly divided into three group, group A（Nifedipine controlled release tablets）, group B（Nifedipine extended release tablets） and group C（Nifedipine common tablets）, with 40 cases in each. Results There was no significant difference in the therapeutic effect among the three groups（P 0.05）. While the adverse reaction of group A was lower than those of group B and group C, the treatment cost was higher than those of group B and group C. Conclusion Although the treatment cost of Nifedipine extended release tablets is not the lowest, but its caplendus is the simplest with less adverse reaction, so it is the ideal dosage form for the treatment of hypertension.
出处
《深圳中西医结合杂志》
2014年第4期174-175,共2页
Shenzhen Journal of Integrated Traditional Chinese and Western Medicine
关键词
硝苯地平
常用剂型
高血压
经济效益
Nifedipine
Common dosage form
Hypertension
Economic returns
